D-Ornithine

D-Ornithine

SCHEMBL43724

NCCC[C@@H](N)C(=O)O

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ornithine SCHEMBL30563013 1.00
D-Ornithine SCHEMBL1537220 1.00 GSR (0.86)
Ornithine SCHEMBL30695803 1.00
Ornithine SCHEMBL20362354 1.00
Ornithine Aketoglutarate SCHEMBL1326163 1.00 GSR (0.86)
Ornithine SCHEMBL30695804 1.00
Ornithine Aketoglutarate SCHEMBL42530 1.00 GSR (0.86)
Ornithine Aketoglutarate SCHEMBL8578 1.00
Ornithine SCHEMBL624782 1.00 GSR (0.86)
Ornithine SCHEMBL8579 1.00

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 5928 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4747627-A1 METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS Matterworks Inc (US) 2026-05-27 EP claimed
CN-122074077-A Radiolabeled melanocortin 1 receptor-specific alpha-melanocyte stimulating hormone analogs for imaging or therapy 省卫生服务机构 2026-05-22 CN claimed
CN-122070294-A Stable vitreous material based on histidine, arginine and glutamic acid amino acids 阵序补丁有限公司 2026-05-19 CN claimed
WO-2026100725-A1 ANTI-CCR8 ANTIBODY AND ANTIBODY-DRUG CONJUGATE THEREOF 住友ファーマ株式会社 2026-05-15 WO claimed
US-20260098072-A1 METHODS OF STIMULATING APPETITE AND/OR INCREASING BODY WEIGHT USING NON-NATURALLY OCCURRING MELANOCORTIN RECEPTOR ANTAGONIST ANALOGS ENDEVICA BIO INC (US) 2026-04-09 US claimed
EP-4720086-A1 PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR Zealand Pharma A/S (DK) 2026-04-08 EP claimed
EP-4720087-A1 PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR Zealand Pharma A/S (DK) 2026-04-08 EP claimed
EP-4696699-A1 ? OPIOID RECEPTOR AGONIST AND USE THEREOF Chengdu Aoda Biotechnology Co., Ltd. (CN) 2026-02-18 EP claimed
EP-4696700-A1 LONG-ACTING K-OPIOID RECEPTOR AGONIST Chengdu Aoda Biotechnology Co., Ltd (CN) 2026-02-18 EP claimed
EP-4691482-A1 LONG-ACTING CALCITONIN ANALOG Chengdu Aoda Biotechnology Co., Ltd. (CN) 2026-02-11 EP claimed
EP-0533795-A1 COMPOSITION OF AND TREATMENT WITH BIOLOGICALLY ACTIVE PEPTIDES HAVING D-AMINO ACID RESIDUES MAGAININ PHARMACEUTICALS, INC. (US) 1993-03-31 EP claimed
WO-1991017760-A1 COMPOSITION OF AND TREATMENT WITH BIOLOGICALLY ACTIVE PEPTIDES HAVING D-AMINO ACID RESIDUES MAGAININ SCIENCES INC. (US) 1991-11-28 WO claimed
EP-0449973-A1 POLYPEPTIDE-POLYMER CONJUGATES ACTIVE IN WOUND HEALING. JOLLA CANCER RES FOUND (US) 1991-10-09 EP claimed
WO-1990006767-A1 POLYPEPTIDE-POLYMER CONJUGATES ACTIVE IN WOUND HEALING LA JOLLA CANCER RESEARCH FOUNDATION (US) 1990-06-28 WO claimed
US-4824660-A Method of determining the viability of tissue in an organism Angello, Paul S. (US) 1989-04-25 US claimed
US-4751299-A Optically active β-lactams and method of their production TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1988-06-14 US claimed
EP-0174979-A4 METHOD OF LOWERING BLOOD SUGAR LEVEL IN VERTEBRATES. ERK VERNON 1987-11-23 EP claimed
EP-0174979-A1 METHOD OF LOWERING BLOOD SUGAR LEVEL IN VERTEBRATES ERK, Vernon (US) 1986-03-26 EP claimed
WO-1985003872-A1 METHOD OF LOWERING BLOOD SUGAR LEVEL IN VERTEBRATES ERK VERNON 1985-09-12 WO claimed
US-4337247-A ANALGESICS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1982-06-29 US claimed